Literature DB >> 31819396

Comprehensive Effects of Organized Education for Patients with Chronic Obstructive Pulmonary Disease.

Hyun Jung Jin1, Kwan Ho Lee1, Jong Geol Jang1, Jee Seon Kim2, Jin Hong Chung1, Kyeong Cheol Shin1, June Hong Ahn1, Mi Sook Lee3, So Hee Bang3, Da Yeong Park3, Mee Jung Nam3.   

Abstract

Background: Despite the increasing prevalence of chronic obstructive pulmonary disease (COPD) worldwide, knowledge and awareness of COPD remain extremely low. This prospective study aimed to demonstrate the effectiveness of organized educational intervention. Patients and methods: The study participants included patients diagnosed with COPD and receiving inhaler treatment. In this prospective study, the patients made three sequential visits to the hospital (baseline, 1 month, 3 months). On their first and second visits, patients received systematic education about COPD. On their first and third visits, each patient was evaluated using a COPD Assessment Test, COPD Knowledge Questionnaire, Hospital Anxiety and Depression Scale, and Rosenberg Self-Esteem Scale.
Results: Fifty-five participants were enrolled in the study. The mean COPD knowledge score before and after education was 12.51±3.19 and 17.89±1.37, respectively, indicating a significant increase in the score post-education (P<0.001). The measure of patients' inhaler technique also significantly improved after education (5.40±1.50 vs 6.83±0.37 P=0.01). The rate of depression and anxiety after education decreased by 10.9% and 12.7%, respectively (P<0.001). In subgroup analysis, we compared the groups whose knowledge score increased by more than 5 points (Group B) and those whose score did not improve (Group A). In Group B, the mean CAT score significantly improved (2.61±5.88 vs -2.41±7.48, P=0.01), and the duration of their COPD diagnosis before enrollment was significantly shorter (2.72±2.43 vs 5.22±5.11 years, P=0.038) compared to those in Group A.
Conclusion: An organized educational program resulted in improved disease-specific knowledge. Disease-specific education is an important part of the treatment of COPD that affects the quality of life and emotional status of patients. Early education after COPD diagnosis can be beneficial.
© 2019 Jang et al.

Entities:  

Keywords:  anxiety; chronic obstructive pulmonary disease; depression; education; quality of life

Mesh:

Substances:

Year:  2019        PMID: 31819396      PMCID: PMC6883930          DOI: 10.2147/COPD.S221673

Source DB:  PubMed          Journal:  Int J Chron Obstruct Pulmon Dis        ISSN: 1176-9106


Introduction

Chronic obstructive pulmonary disease (COPD) is a common, progressive disease with persistent respiratory symptoms and airflow limitation.1,2 COPD is a major cause of chronic morbidity and mortality worldwide and is expected to be the third leading cause of death in 2030.3 A great number of patients with COPD have a poor knowledge of COPD and a misunderstanding of their own symptom control state.4,5 Thus, disease-specific education is an important part of management for patients with COPD,6 and enhancing patient knowledge will lead to improved self-management.7 The goal of education is to improve adherence of treatment and clinical outcome.8 Up to now, disease education has been implemented as part of pulmonary rehabilitation, and most studies reported that education alone did not impact on the quality of life.9 The purpose of this study was to develop an education program and evaluate the effectiveness of an organized education program in improving disease-specific knowledge and quality of life of patients with COPD.

Methods

Patient

Patients were recruited from a tertiary hospital in South Korea. Enrollment occurred from 2017 to 2018. The study included patients aged >40 years, with diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria1 and receiving ongoing treatment with an inhaler. Exclusion criteria were as follows: 1) the patient who is impossible to communicate in written or spoken Korean and 2) the patient who had received prior education of COPD in the last year. This study was conducted in accordance with the Declaration of Helsinki and was reviewed and approved by the Institutional Review Board of Yeungnam University Hospital (IRB number YUMC IRB 2017-08-027). All patients provided written informed consent before participating in the study.

Study Design and Intervention

This trial was a prospective study comparing specific patient metrics before and after educational intervention. Participants visited the facility three times and received two sessions of face-to-face education individually, each lasting 30 mins, with a nurse with expertise in managingpatients with COPD and a pulmonologist (first session and final refreshment were conducted by the nurse and second session by the pulmonologist). Intervention was conducted by using a leaflet made by the pulmonologist and it was given to the patients after the educational session. Contents of the first educational session (on enrollment) were as follows: definition of COPD, COPD diagnosis, pulmonary function test, signs and symptoms, treatment, vaccination, and nutrition. Contents of the second educational session (1 month after the first visit) included correct use of an inhaler, benefits of exercise and physical activities, recognition and action plan of acute exacerbation, and management of comorbidities. At their third visit (3 months after the first visit), we assessed the change in each patient metric. Thereafter, the prior educational contents were refreshed ().

Outcome Measures

At baseline, data on age, gender, body mass index, level of education, history of smoking, comorbidities, duration of COPD diagnosis, and spirometric measures (forced vital capacity (FVC), forced expired volume in 1 second (FEV1) and FEV1/FVC ratio) were collected. The primary outcome was the change in COPD knowledge after education. It was assessed using 20 statements about COPD-related topics. It consisted of 8 topics and 20 items (). The 17 items on the questionnaire were a modification of the Bristol COPD Knowledge Questionnaire10 (BCKQ) and 3 items used were quoted from Lee et al.11 The secondary outcomes were the change in the modified Medical Research Council (mMRC) Dyspnea Scale score, COPD Assessment Test (CAT) score, Rosenberg Self-Esteem Scale (RSES) score, Hospital Anxiety and Depression Scale (HADS) score, and patient inhaler technique after education. All outcomes were measured at the first visit and third visit (3 months after the first visit). The mMRC scale consists of five statements that describe the range of dyspnea from none (grade 0) to almost complete incapacity (grade 4).12 The CAT score contains eight questions that cover domains relating to the impact of COPD symptoms and range from 0 to 40, with higher scores indicating more severe disease.13 The RSES is a widely used measure of self-esteem and includes a 10-item Likert scale with items answered on a four-point scale, from strongly agree to strongly disagree.14 The HADS measurement was acquired via a self-assessment questionnaire to assess the state of anxiety and depression among the medically ill patients.15 It is a 14-item questionnaire composed of 7 items each for the anxiety subscale and depression.15 A possible presence of anxiety and depression can be considered when the HADS score is ≥8. The inhaler technique was assessed by using a scoring system that consists of seven steps (). The checklist of inhalers was made based on previous studies.11,16 The final score is reported as the sum of the scores for each step (1 for a correct answer, 0 for an incorrect or skipped answer).

Sample Size Calculation and Statistical Analysis

Calculation using power analysis indicated that the overall sample size of 44 patients was required to detect 15% improvement of knowledge score after education by using a paired t-test (90% power, α=0.05, effect size=0.5). The 15% improvement was chosen because the previous study reported a 15% improvement of knowledge after educational intervention. Eleven participants were added to allow for a 20% drop-out rate. Continuous variables were compared using Student’s t-test or the Mann−Whitney U-test and are expressed as the mean±standard deviation (SD). Categorical variables were compared using the Chi-square test or Fisher’s exact test. A comparison of differences in values of variables before and after education was conducted using a paired t-test. In all analyses, a P value of <0.05 was considered as indicative of statistical significance based on two-tailed tests. All statistical procedures were performed using SPSS software (version 21.0; IBM Corp., Armonk, NY, USA).

Results

A total of 55 patients were enrolled and their data were analyzed. The baseline characteristics are shown in Table 1. The participants were 68.2±7.9 years and the majority were male (n=54, 98.2%).
Table 1

Baseline Clinical Characteristics

CharacteristicsScore
Gender, male/female, n54/1
Age (years)68.2±7.9
 ≤5910.9 (6)
 60–6927.3 (15)
 70–7950.9 (28)
 ≥8010.9 (6)
Smoking status
 Current smoking16.4 (9)
 Former smoking80.0 (44)
 Never smoking3.6 (2)
Body mass index (kg/m2)23.4±3.4
Spirometric value (post-bronchodilator)
 FEV1 (% predicted)64.3±14.5
 FEV1/FVC59.8±13.7
mMRC dyspnea scale score1.2±0.9
Highest level of education complete
 Primary school or lower38.2 (21)
 Middle school14.5 (8)
 High school20.0 (11)
 College27.3 (15)
Underlying disease
 Cardiovascular disease9.1 (5)
 Heart failure1.8 (1)
 Hypertension38.2 (21)
 Diabetes mellitus23.6 (13)
Time since COPD diagnosis (years)3.5±3.7

Note: Data are presented as mean±SD and percentage (number) unless otherwise stated.

Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; mMRC, modified Medical Research Council; COPD, chronic obstructive pulmonary disease.

Baseline Clinical Characteristics Note: Data are presented as mean±SD and percentage (number) unless otherwise stated. Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; mMRC, modified Medical Research Council; COPD, chronic obstructive pulmonary disease.

Primary Outcome

The mean score of COPD knowledge before and after education is presented in Table 2. Compared with the knowledge score before education, the score improved significantly after education (12.51±3.19 vs 17.89±1.37; P < 0.001), with a mean change of 5.38±2.90. The number of correct responses for each item on the knowledge questionnaire improved, andthe result is presented in .
Table 2

Change of Measures Before and After Education

MeasuresBefore Education (n=55)After Education (n=55)P-Value
Knowledge score12.51±3.1917.89±1.37<0.001
Inhaler technique score5.40±1.506.83±037<0.001
FEV1 (% predicted)64.00±14.1566.09±15.600.050
CAT score14.15±8.1213.83±9.330.753
RSE scale19.75±4.5420.25±3.830.422
HADS
 Anxiety score5.31±5.405.11±5.150.664
 Depression score7.15±5.436.35±4.660.155
 Patients with HAS ≥8, n (%)15 (27.3)9 (16.4)0.001
 Patients with HDS ≥8, n (%)22 (40)15 (27.3)0.001

Note: Data are presented as mean±SD unless otherwise stated. Measures were collected at baseline and third visit (3 months after the first visit).

Abbreviations: FEV1, forced expiratory volume in 1 second; CAT, COPD Assessment Test; RES, Rosenberg self-esteem scale; HADS, Hospital Anxiety and Depression Scale.

Change of Measures Before and After Education Note: Data are presented as mean±SD unless otherwise stated. Measures were collected at baseline and third visit (3 months after the first visit). Abbreviations: FEV1, forced expiratory volume in 1 second; CAT, COPD Assessment Test; RES, Rosenberg self-esteem scale; HADS, Hospital Anxiety and Depression Scale.

Secondary Outcome

Changes in secondary outcomes between baseline (first visit before education) and third visit are presented in Table 2. Patient inhaler technique was improved following education (5.42±1.50 vs 6.83±0.37). Patient HADSscore also decreased but not significantly (5.31±5.40 vs 5.11±5.15, 7.15±5.43 vs 6.35±4.66, respectively). However, the prevalence of depression and anxiety after education decreased significantly (27.3% vs 16.4%, 40% vs 27.3%, respectively). Patient CAT score decreased but not significantly (14.15±8.12 vs 13.83±9.33; P=0.753). There was no measured difference in mean patient RSES score following education (19.75±4.54 vs 20.25±3.83; P=0.606). FEV1 improved after education but not significantly (64.00±14.15 vs 66.09±15.60; P=0.050). A comparison was made between the group whose knowledge had increased by more than 5 points (Group B) and the group whose knowledge had not (Group A). Group A had 23 patients and Group B had 32 patients. There was no difference in the level of education between the two groups. In Group B, the CAT score after education was significantly improved (2.61±5.88 vs −2.41±7.48, P=0.01) and the duration of COPD diagnosis before enrollment was significantly shorter (2.72±2.43 vs 5.22±5.11 years, P=0.038) compared to Group B (Table 3).
Table 3

Comparison Between Two Groups

MeasuresGroup A (n=23)Group B (n=32)P-Value
Age68.96±7.6867.63±8.080.541
Education, n (%)0.138
 Primary7 (30.4)14 (43.8)
 Middle6 (26.1)2 (6.3)
 High school3 (13.0)8 (25)
 College7 (30.4)8 (25)
FEV161.52±11.7265.78±15.600.275
mMRC1.26±0.921.13±0.910.588
Time since COPD diagnosis (years)5.22±5.112.73±2.430.038
CAT12.43±7.8015.37±8.240.188
RES20.09±3.8519.6±5.030.641
HADS
 Anxiety5.17±5.705.41±5.270.877
 Depression6.91±5.487.31±5.480.791
Δ CAT−2.61±5.882.41±7.480.010
Δ RES0.0±3.950.88±5.140.304
Δ Inhaler technique−1.39±1.47−1.47±1.480.849
Δ HADS
 Δ Anxiety−0.52±2.750.72±3.740.105
 Δ Depression0.26±3.831.19±4.320.599
Δ FEV1−0.70±5.61−3.09±9.050.223

Notes: Group A: less than 5 points increase of knowledge score after disease education; Group B: equal or more than 5 points increase of knowledge score after disease education.

Abbreviations: FEV1, forced expiratory volume in 1 second; mMRC, modified Medical Research Council; COPD, chronic obstructive pulmonary disease; CAT, COPD Assessment test; RES, Rosenberg self-esteem; HADS, Hospital Anxiety and Depression Scale; Δ=change in score (scores collected at baseline – scores collected at visit 3).

Comparison Between Two Groups Notes: Group A: less than 5 points increase of knowledge score after disease education; Group B: equal or more than 5 points increase of knowledge score after disease education. Abbreviations: FEV1, forced expiratory volume in 1 second; mMRC, modified Medical Research Council; COPD, chronic obstructive pulmonary disease; CAT, COPD Assessment test; RES, Rosenberg self-esteem; HADS, Hospital Anxiety and Depression Scale; Δ=change in score (scores collected at baseline – scores collected at visit 3).

Discussion

The aim of this study was to provide systematic intensive education to patients with COPD for a short period and to identify the effects of this education comprehensively. To date, there are no studies investigating the appropriate duration of education required to be effective, but several studies have shown that long-term education (12 months,17 48 months18) resulted in a meaningful effect. We wanted to see whether short-term education was as effective as long-term education. For this purpose, a nurse was assigned and trained to educate patients with COPD, and five dedicated respiratory physicians, each with over 10 years of experience, created the contents of the educational program for patients. As shown in the results, two sessions of the face-to-face educational program resulted in a clinical improvement in disease-specific knowledge, enhanced inhaler technique, and a decreased rate of anxiety and depression. Although pulmonary rehabilitation improved the mean patient CAT score,19 most studies did not show that education alone improves health-related quality of life.20 Our study also failed to prove that disease education affects patient quality of life, as no significant change in mMRC scale and CAT score was observed following education. However, when we made a comparison between the group whose knowledge score after education had increased by 5 points or more (Group B) and those whose knowledge score had not (Group A), the CAT score was significantly improved in Group A. This result may indicate that the more effectively educated group could see benefits with regard to symptom control. Our results also revealed that the duration between COPD diagnosis and receipt of education was shorter in Group A, suggesting that early detection and disease education might enhance disease-specific knowledge and health-related quality of life. We measured disease-specific knowledge using 17 items from domains in BCKQ10 and 3 items from the article by Lee et al.11 In treatment-related topics, we wanted to emphasize the importance of actual usage of inhaler since treatment adherence is associated with symptom improvement, enhancement of exercise capacity, and quality of life. Therefore, instead of using items in BCKQ which contains more technical questions, we used the items from the study of Lee et al.11 The correct response rate for nearly all items of the questionnaire, as well as total score of knowledge, also improved after education, even though not all scores improved to 100%. The correct response rate for treatment-related questions, which was one of the most emphasized parts during the education, improved to 100% after education. The topics that were answered incorrectly most frequently before education were regarding epidemiology and vaccination, such as “In COPD the word ‘chronic’ means it is severe”, and “A pneumonia jab protects against all forms of pneumonia.” The correct response rate of these topics still remained lowest compared to others even though a slight improvement was shown after education. The low percentage of correct answers to the COPD-definition question demonstrates that awareness for the disease is still low. This point will be more heavily emphasized in future COPD education. Anxiety and depression are common psychological problems and are associated with a poor prognosis in COPD.21,22 Depression is a significant predictor of medical adherence23 and its prevalence among patients with COPD ranges from 10% to 42%22 and increases with the severity of COPD.24 In this study, the frequency of anxiety and depression among participants was 27% and 40%, respectively, which was similar to that reported previously. Lou et al reported that the incidence of anxiety and depression in the intervention group was significantly lower than in the control group at 48-month assessment,18 but studies on the effectiveness of short-term education and follow-up on anxiety and depression in patients with COPD are relatively rare. As shown in our results, there was no significant change in patient HADS score following education, but the incidence of anxiety and depression was significantly lower after education. Our study showed that the incidence of anxiety and depression was significantly reduced following short-term education, and it is presumed to be due to increased awareness of the disease through education. Several studies have been conducted that indicate the beneficial effects of pulmonary rehabilitation, including the effects of disease education on self-esteem.25,26 However, there are no studies to date on the relationship between education only and self-esteem. We aimed to assess the effect of education on patients’ self-esteem by using the RSES.14 However, our study did not show a significant relationship between the two. When answering the question about self-esteem, most of the patients did not understand the questions correctly and many hesitated to answer to “strongly agree” or “strongly disagree”. Along with this, the small sample size of our study may have also affected the reliability of the study result. More studies are needed to investigate the relationship between education and self-esteem. Our study has several limitations. First, our knowledge score was not validated although we quoted many of the items from some parts of the BCKQ. Since the number of questions on the BCKQ is substantial, the patient’s concentration during assessment might decrease and this may lead to unreliable results. However, our questionnaire includes essential items from BCKQ and its validity was confirmed with the consent of five physicians who each had more than 10 years of experience in respiratory medicine. Thus, we assumed that it was appropriate for assessing patient disease-specific knowledge of COPD. Second, due to our small sample size and relatively short-term follow-up period, it was difficult to show a significant association between disease education and its effect on variable measures. However, through short but intensive education, we found that short-term education is also effective. The third limitation of our study is the absence of a control group. We did not recruit a control group because we evaluated the effect of disease education through comparing measures before and after the education in the same patients. As shown in our results, we found important findings in subgroup analysis. But, if our study included an uneducated control group from the beginning, our study could have resulted in a higher level of evidence and ruled out factors that would interfere with the interpretation of the results. The fourth limitation of our study is a remarkably high proportion of male participants at the time of enrollment. This is probably due to the fact that the prevalence of COPD in Korea is still much higher in males than in females,27 and voluntary participation in the study (without gender matching step at the time of enrollment) has led to an extreme increase in the ratio of males. However, in previous studies, the impact of education by gender difference has not been reported.18,28 Therefore, we assumed that there would be no significant problem in interpreting the results of our study.

Conclusion

An organized educational program resulted in improved patient disease-specific knowledge. Disease-specific education is an important part of the treatment of COPD that affects the quality of life and emotional status of patients. Early education after COPD diagnosis is recommended, and the earlier the education starts, the better the result expected.
  27 in total

1.  Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Authors:  David B Price; Miguel Román-Rodríguez; R Brett McQueen; Sinthia Bosnic-Anticevich; Victoria Carter; Kevin Gruffydd-Jones; John Haughney; Svein Henrichsen; Catherine Hutton; Antonio Infantino; Federico Lavorini; Lisa M Law; Karin Lisspers; Alberto Papi; Dermot Ryan; Björn Ställberg; Thys van der Molen; Henry Chrystyn
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

2.  Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  E Monninkhof; P van der Valk; T Schermer; J van der Palen; C van Herwaarden; G Zielhuis
Journal:  Chron Respir Dis       Date:  2004       Impact factor: 2.444

3.  Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey.

Authors:  Dong Soon Kim; Young Sam Kim; Ki-Suck Jung; Jung Hyun Chang; Chae-Man Lim; Jae Ho Lee; Soo-Taek Uh; Jae Jeong Shim; Woo Jin Lew
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

4.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

5.  Depression and health-related quality of life in chronic obstructive pulmonary disease.

Authors:  Theodore A Omachi; Patricia P Katz; Edward H Yelin; Steven E Gregorich; Carlos Iribarren; Paul D Blanc; Mark D Eisner
Journal:  Am J Med       Date:  2009-08       Impact factor: 4.965

6.  Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Kylie Hill; Suzanna Mangovski-Alzamora; Maria Blouin; Gordon Guyatt; Diane Heels-Ansdell; Pauline Bragaglia; Itamar Tamari; Karen Jones; Roger Goldstein
Journal:  Patient Educ Couns       Date:  2009-10-22

Review 7.  Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Authors:  Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

8.  Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial.

Authors:  Carme Hernández; Albert Alonso; Judith Garcia-Aymerich; Ignasi Serra; Dolors Marti; Robert Rodriguez-Roisin; Georgia Narsavage; Maria Carmen Gomez; Josep Roca
Journal:  NPJ Prim Care Respir Med       Date:  2015-04-09       Impact factor: 2.871

9.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits.

Authors:  Haamid H Siddique; Raymond H Olson; Connie M Parenti; Thomas S Rector; Michael Caldwell; Naresh A Dewan; Kathryn L Rice
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-25
View more
  4 in total

1.  The effects of repeated inhaler device handling education in COPD patients: a prospective cohort study.

Authors:  June Hong Ahn; Jin Hong Chung; Kyeong-Cheol Shin; Hyun Jung Jin; Jong Geol Jang; Mi Suk Lee; Kwan Ho Lee
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

2.  Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients.

Authors:  Jong Geol Jang; Jin Hong Chung; Kyeong-Cheol Shin; Hyun Jung Jin; Kwan Ho Lee; June Hong Ahn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-19

3.  Qualitative Evaluation of a Novel Educational Tool to Communicate Individualized Hip Fracture Prognostic Information to Patients and Surrogates: My Hip Fracture (My-HF).

Authors:  Corita Vincent; Pete Wegier; Vincent Chien; Allison Miyoshi Kurahashi; Shiphra Ginsburg; Hedieh Molla Ghanbari; Jesse Isaac Wolfstadt; Peter Cram
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-10-23

4.  A Retrospective Study of Diaphragmatic Breathing Training Combined with Discharge Care Bundles in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shuhui Yu; Chen Lu; Lingling Qin
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-14       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.